# A Study of TAK-660 in Surgical Procedures for People With Hemophilia A.

> **NCT04941898** · — · COMPLETED · sponsor: **Takeda** · enrollment: 16 (actual)

## Conditions studied

- Hemophilia A

## Interventions

- **BIOLOGICAL:** PEGylated Recombinant Factor VIII

## Key facts

- **NCT ID:** NCT04941898
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-30
- **Primary completion:** 2024-03-15
- **Final completion:** 2024-03-15
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2024-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04941898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04941898, "A Study of TAK-660 in Surgical Procedures for People With Hemophilia A.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04941898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*